Lara Ann Harvey
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Lara Ann Harvey has a total of 112 co-authors. Here are the top co-authors by number of shared publications:
- Rebecca Mitchell
Australian Institute of Health Innovation, Macquarie University, Sydney, Australia
11 shared publications Jacqueline Close
School of Clinical Medicine, UNSW, Prince of Wales Clinical School Sydney Australia
8 shared publications- Wadad Kathy Tannous
Western Sydney University
6 shared publications Brian Draper
Dementia Centre for Research Collaboration School of Psychiatry University of New South Wales Sydney NSW Australia
5 shared publications- Brian Draper
Discipline of Psychiatry and Mental Health University of New South Wales Sydney Australia
5 shared publications - Gulay Avsar
School of Business, Western Sydney University, Parramatta, NSW 2150, Australia
5 shared publications
Latest Publications
- Open Access
- 26 February 2026
- Published by Wiley in Anz Journal of Surgery
- Vol. 96 (4) , 912-928
Temporal Trends in Pancreatic Cancer in New South Wales, Australia: A Longitudinal Population‐Based Study of Incidence, Surgery and Survival
Introduction: The incidence of pancreatic adenocarcinoma is increasing, as is the proportion of patients undergoing pancreatectomy. This study aimed to identify temporal trends in incidence, survival and pancreatectomy uptake in New South Wales (NSW), in patients aged 50 years and older diagnosed with pancreatic and periampullary cancer. Methods: This study linked NSW Hospitalisation, Death, and Cancer Registry data. Analysis included patients aged 50 years and older diagnosed or admitted for pancreatic or periampullary cancer (2009–2018). We analysed temporal trends in incidence and age‐standardised rates of pancreatic cancer, pancreatectomy rates, and 1‐, 3‐ and 5‐year post‐diagnosis survival. Results: Thirteen thousand five hundred and sixty patients were identified, with annual cases increasing from 1148 to 1591. Age‐standardised pancreatic cancer rates increased from 50.3/100 000 to 56.3/100 000 population, an annual increase from 2009 to 2018 of 1.5% (95% CI 1.0–2.0). From 2009 to 2018, one‐ (27.7% vs. 39.7%) and three‐ (13.8% vs. 20.9%) year survival improved, and an increased proportion of patients underwent resection (14.5% to 21.4%). Five‐year survival similarly improved (11.6% vs. 19.0%) between 2009 and 2016. Pancreaticoduodenectomy rates decreased, and non‐pancreaticoduodenectomy resection rates increased. An increased proportion of pancreatectomies were conducted in high volume centres (≥ 16 pancreatectomies). Diagnosis in a later year improved survival in both the whole, and the surgical cohorts at all endpoints. Conclusions: In NSW, rates of pancreatic and periampullary cancer in people aged 50 years and older have risen. Despite remaining a disease of high mortality, survival has improved over a 10‐year period, and resection is increasingly utilised.
- 26 February 2026
- Published by Wiley in Anz Journal of Surgery
- Vol. 96 (4) , 912-928
Open AccessTemporal Trends in Pancreatic Cancer in New South Wales, Australia: A Longitudinal Population‐Based Study of Incidence, Surgery and Survival
Introduction: The incidence of pancreatic adenocarcinoma is increasing, as is the proportion of patients undergoing pancreatectomy. This study aimed to identify temporal trends in incidence, survival and pancreatectomy uptake in New South Wales (NSW), in patients aged 50 years and older diagnosed with pancreatic and periampullary cancer. Methods: This study linked NSW Hospitalisation, Death, and Cancer Registry data. Analysis included patients aged 50 years and older diagnosed or admitted for pancreatic or periampullary cancer (2009–2018). We analysed temporal trends in incidence and age‐standardised rates of pancreatic cancer, pancreatectomy rates, and 1‐, 3‐ and 5‐year post‐diagnosis survival. Results: Thirteen thousand five hundred and sixty patients were identified, with annual cases increasing from 1148 to 1591. Age‐standardised pancreatic cancer rates increased from 50.3/100 000 to 56.3/100 000 population, an annual increase from 2009 to 2018 of 1.5% (95% CI 1.0–2.0). From 2009 to 2018, one‐ (27.7% vs. 39.7%) and three‐ (13.8% vs. 20.9%) year survival improved, and an increased proportion of patients underwent resection (14.5% to 21.4%). Five‐year survival similarly improved (11.6% vs. 19.0%) between 2009 and 2016. Pancreaticoduodenectomy rates decreased, and non‐pancreaticoduodenectomy resection rates increased. An increased proportion of pancreatectomies were conducted in high volume centres (≥ 16 pancreatectomies). Diagnosis in a later year improved survival in both the whole, and the surgical cohorts at all endpoints. Conclusions: In NSW, rates of pancreatic and periampullary cancer in people aged 50 years and older have risen. Despite remaining a disease of high mortality, survival has improved over a 10‐year period, and resection is increasingly utilised.
- Open Access
- 29 August 2025
- Published by Oxford University Press (OUP) in Age and Ageing
- Vol. 54 (10)
Long-acting intranasal insulin for the treatment of delirium—a randomised clinical trial
Background: Delirium affects up to 25% of hospitalised older patients; however, there are no effective pharmacological treatments. Accumulating evidence of brain insulin resistance and altered cerebral glucose metabolism during delirium present a promising therapeutic target. Objective: To assess the safety and efficacy of intranasal insulin in the treatment of delirium. Design: Single-centre, randomised, double-blind, placebo-controlled trial. Setting: Two geriatric medicine wards in a tertiary hospital. Participants: 100 patients aged over 64 years presenting to hospital and admitted under geriatric medicine with delirium. Interventions: Participants were randomised in a 1:1 ratio to receive 20 IU of long-acting insulin or placebo intranasally twice daily until delirium resolution, hospital discharge or intervention futility defined by prespecified criteria. Main outcome: The primary outcome was delirium duration, assessed daily using the Confusion Assessment Method. Secondary outcomes included acute length of stay (LOS), delirium severity, antipsychotic use, hospital complications and mortality. Results: The intention-to-treat analysis included 97 participants [intranasal insulin n = 48, control n = 49; mean (SD) age, 87.6 (7.0) years; 63% female]. Baseline characteristics were similar between groups. Median delirium duration [days (IQR)] was 4.8 [2.9, 9.2] for intranasal insulin and 6.8 [4.0, 9.8] for the control (HR 0.7, 95% CI 0.43–1.15; P = .16). Median acute LOS (days) was 7.9 [4.6, 14.5] for intranasal insulin and 12.9 [6.9, 16.8] for the control (HR 0.56, 0.35–0.89; P = .014). No significant differences were observed in other secondary outcomes. Intranasal insulin demonstrated favourable tolerability. Overall, 86% of the participants were compliant with the intervention (≥80% of doses). Prespecified subgroup analysis revealed an age-related response, with participants aged ≤88 years showing shorter delirium duration with intranasal insulin [n = 46; intranasal insulin: median 3.9 (IQR 2.9, 6.9) days vs control: 7.0 (4.7, 9.7); HR 0.34, 0.16–0.74; P = .006], whereas no difference was observed in participants aged >88 years [n = 51; intranasal insulin 5.4 (2.9, 11.1) vs control 4.9 (2.6, 12.9); HR 0.87, 0.39–1.94; P = .73]. Conclusion and relevance: This is the first study of intranasal insulin for delirium treatment. The reduced LOS combined with the observed age-related effects warrants further investigation into the clinical potential of intranasal insulin in managing delirium in older patients. Trial registration: ACTRN 12618000318280.
- 29 August 2025
- Published by Oxford University Press (OUP) in Age and Ageing
- Vol. 54 (10)
Open AccessLong-acting intranasal insulin for the treatment of delirium—a randomised clinical trial
Background: Delirium affects up to 25% of hospitalised older patients; however, there are no effective pharmacological treatments. Accumulating evidence of brain insulin resistance and altered cerebral glucose metabolism during delirium present a promising therapeutic target. Objective: To assess the safety and efficacy of intranasal insulin in the treatment of delirium. Design: Single-centre, randomised, double-blind, placebo-controlled trial. Setting: Two geriatric medicine wards in a tertiary hospital. Participants: 100 patients aged over 64 years presenting to hospital and admitted under geriatric medicine with delirium. Interventions: Participants were randomised in a 1:1 ratio to receive 20 IU of long-acting insulin or placebo intranasally twice daily until delirium resolution, hospital discharge or intervention futility defined by prespecified criteria. Main outcome: The primary outcome was delirium duration, assessed daily using the Confusion Assessment Method. Secondary outcomes included acute length of stay (LOS), delirium severity, antipsychotic use, hospital complications and mortality. Results: The intention-to-treat analysis included 97 participants [intranasal insulin n = 48, control n = 49; mean (SD) age, 87.6 (7.0) years; 63% female]. Baseline characteristics were similar between groups. Median delirium duration [days (IQR)] was 4.8 [2.9, 9.2] for intranasal insulin and 6.8 [4.0, 9.8] for the control (HR 0.7, 95% CI 0.43–1.15; P = .16). Median acute LOS (days) was 7.9 [4.6, 14.5] for intranasal insulin and 12.9 [6.9, 16.8] for the control (HR 0.56, 0.35–0.89; P = .014). No significant differences were observed in other secondary outcomes. Intranasal insulin demonstrated favourable tolerability. Overall, 86% of the participants were compliant with the intervention (≥80% of doses). Prespecified subgroup analysis revealed an age-related response, with participants aged ≤88 years showing shorter delirium duration with intranasal insulin [n = 46; intranasal insulin: median 3.9 (IQR 2.9, 6.9) days vs control: 7.0 (4.7, 9.7); HR 0.34, 0.16–0.74; P = .006], whereas no difference was observed in participants aged >88 years [n = 51; intranasal insulin 5.4 (2.9, 11.1) vs control 4.9 (2.6, 12.9); HR 0.87, 0.39–1.94; P = .73]. Conclusion and relevance: This is the first study of intranasal insulin for delirium treatment. The reduced LOS combined with the observed age-related effects warrants further investigation into the clinical potential of intranasal insulin in managing delirium in older patients. Trial registration: ACTRN 12618000318280.
- Open Access
- 11 March 2025
- Published by Springer Nature in BMC Health Services Research
- Vol. 25 (1) , 363
Health service utilisation cost associated with residential fire incidents in New South Wales, Australia
Fire is a major contributor to global fatalities and disabilities and remains a prevalent threat to individuals in Australia. New South Wales (NSW) experiences over one-third of all structure fires, including residential ones, in the country and one-quarter of all associated deaths and hospital admissions. In an atmosphere of rising healthcare cost and heightened demand for its services, obtaining total cost data for residential fires is essential. The study aims to estimate the cost of health service utilisation, including ambulance, emergency, and hospital admission, resulting from residential fire incidents in NSW, Australia. This population-based cohort study uses response and health service administration data from 1 January 2005 to 31 December 2014. The data sources are Australian Computer Aided Dispatch system, Fire and Rescue NSW Australian Incident Reporting System, NSW Ambulance datasets, NSW Emergency Department Data Collections, and NSW Admitted Patient Data Collection which are administrative datasets that have been linked. Cost figures were expressed in constant 2023 Australian dollars. The estimated annual average cost for ambulance use was AU$75 thousand, with the average cost per use of AU$945. The average annual cost for emergency department visits was AU$137 thousand, and the average cost per visit was AU$890. The average total length of stay in hospital was nine days. The average annual cost of episodes of care in hospital was estimated at AU$4 million, with the average cost per episode of care of AU$16,140. The study assessed the total cost for health service use relevant to residential fire incidents and associated injuries at AU$46 million over time, averaging approximately AU$5 million annually. This study provided, for the first time, total and average costs of health service utilisation per type for ambulance use, ED visits, and hospital admissions associated with residential fire incidents and related injuries using linked administrative data in NSW. Our study will assist the government and stakeholders in making informed decisions that prioritise funding for healthcare service and improve the quality of overall fire safety and public health outcomes.
- 11 March 2025
- Published by Springer Nature in BMC Health Services Research
- Vol. 25 (1) , 363
Open AccessHealth service utilisation cost associated with residential fire incidents in New South Wales, Australia
Fire is a major contributor to global fatalities and disabilities and remains a prevalent threat to individuals in Australia. New South Wales (NSW) experiences over one-third of all structure fires, including residential ones, in the country and one-quarter of all associated deaths and hospital admissions. In an atmosphere of rising healthcare cost and heightened demand for its services, obtaining total cost data for residential fires is essential. The study aims to estimate the cost of health service utilisation, including ambulance, emergency, and hospital admission, resulting from residential fire incidents in NSW, Australia. This population-based cohort study uses response and health service administration data from 1 January 2005 to 31 December 2014. The data sources are Australian Computer Aided Dispatch system, Fire and Rescue NSW Australian Incident Reporting System, NSW Ambulance datasets, NSW Emergency Department Data Collections, and NSW Admitted Patient Data Collection which are administrative datasets that have been linked. Cost figures were expressed in constant 2023 Australian dollars. The estimated annual average cost for ambulance use was AU$75 thousand, with the average cost per use of AU$945. The average annual cost for emergency department visits was AU$137 thousand, and the average cost per visit was AU$890. The average total length of stay in hospital was nine days. The average annual cost of episodes of care in hospital was estimated at AU$4 million, with the average cost per episode of care of AU$16,140. The study assessed the total cost for health service use relevant to residential fire incidents and associated injuries at AU$46 million over time, averaging approximately AU$5 million annually. This study provided, for the first time, total and average costs of health service utilisation per type for ambulance use, ED visits, and hospital admissions associated with residential fire incidents and related injuries using linked administrative data in NSW. Our study will assist the government and stakeholders in making informed decisions that prioritise funding for healthcare service and improve the quality of overall fire safety and public health outcomes.
- Open Access
- 26 September 2024
- Published by Wiley in Medical Journal of Australia
- Vol. 221 (9) , 480-485
Adherence to clinical care standards and mortality after hip fracture surgery in New South Wales, 2015–2018: a retrospective population‐based study
Objectives: To determine whether adherence to hip fracture clinical care quality indicators influences mortality among people who undergo surgery after hip fracture in New South Wales, both overall and by individual indicator.Study design: Retrospective population‐based study; analysis of linked Australian and New Zealand Hip Fracture Registry (ANZHFR), hospital admissions, residential aged care, and deaths data.Setting, participants: People aged 50 years or older with hip fractures who underwent surgery in 21 New South Wales hospitals participating in the ANZHFR, 1 January 2015 – 31 December 2018.Main outcome measures: Thirty‐day (primary outcome), 120‐day, and 365‐day mortality (secondary outcomes) by clinical care indicator adherence level (low: none to three of six indicators achieved; moderate: four indicators achieved; high: five or six indicators achieved) and by individual indicator.Results: Registry data were available for 9236 hip fractures in 9058 people aged 50 years or older during 2015–2018; the mean age of patients was 82.8 years (standard deviation, 9.3 years), 5510 patients were women (69.4%). Complete data regarding adherence to clinical care indicators were available for 7951 fractures (86.1%); adherence to these indicators was high for 5135 (64.6%), moderate for 2249 (28.3%), and low for 567 fractures (7.1%). After adjustment for age, sex, comorbidity, admission year, pre‐admission walking ability, and residential status, 30‐day mortality risk was lower for high (adjusted relative risk [aRR], 0.40; 95% confidence interval [CI], 0.30–0.52) and moderate indicator adherence hip fractures (aRR, 0.61; 95% CI, 0.46–0.82) than for low indicator adherence hip fractures, as was 365‐day mortality (high adherence: aRR, 0.59 [95% CI, 0.51–0.68]; moderate adherence: aRR, 0.74 [95% CI, 0.63–0.86]). Orthogeriatric care (365 days: aRR, 0.78; 95% CI, 0.61–0.98) and offering mobilisation by the day after surgery (365 days: aRR, 0.74; 95% CI, 0.67–0.83) were associated with lower mortality risk at each time point.Conclusions: Clinical care for two‐thirds of hip fractures attained a high level of adherence to the six quality care indicators, and short and longer term mortality was lower among people who received such care than among those who received low adherence care.
- 26 September 2024
- Published by Wiley in Medical Journal of Australia
- Vol. 221 (9) , 480-485
Open AccessAdherence to clinical care standards and mortality after hip fracture surgery in New South Wales, 2015–2018: a retrospective population‐based study
Objectives: To determine whether adherence to hip fracture clinical care quality indicators influences mortality among people who undergo surgery after hip fracture in New South Wales, both overall and by individual indicator.Study design: Retrospective population‐based study; analysis of linked Australian and New Zealand Hip Fracture Registry (ANZHFR), hospital admissions, residential aged care, and deaths data.Setting, participants: People aged 50 years or older with hip fractures who underwent surgery in 21 New South Wales hospitals participating in the ANZHFR, 1 January 2015 – 31 December 2018.Main outcome measures: Thirty‐day (primary outcome), 120‐day, and 365‐day mortality (secondary outcomes) by clinical care indicator adherence level (low: none to three of six indicators achieved; moderate: four indicators achieved; high: five or six indicators achieved) and by individual indicator.Results: Registry data were available for 9236 hip fractures in 9058 people aged 50 years or older during 2015–2018; the mean age of patients was 82.8 years (standard deviation, 9.3 years), 5510 patients were women (69.4%). Complete data regarding adherence to clinical care indicators were available for 7951 fractures (86.1%); adherence to these indicators was high for 5135 (64.6%), moderate for 2249 (28.3%), and low for 567 fractures (7.1%). After adjustment for age, sex, comorbidity, admission year, pre‐admission walking ability, and residential status, 30‐day mortality risk was lower for high (adjusted relative risk [aRR], 0.40; 95% confidence interval [CI], 0.30–0.52) and moderate indicator adherence hip fractures (aRR, 0.61; 95% CI, 0.46–0.82) than for low indicator adherence hip fractures, as was 365‐day mortality (high adherence: aRR, 0.59 [95% CI, 0.51–0.68]; moderate adherence: aRR, 0.74 [95% CI, 0.63–0.86]). Orthogeriatric care (365 days: aRR, 0.78; 95% CI, 0.61–0.98) and offering mobilisation by the day after surgery (365 days: aRR, 0.74; 95% CI, 0.67–0.83) were associated with lower mortality risk at each time point.Conclusions: Clinical care for two‐thirds of hip fractures attained a high level of adherence to the six quality care indicators, and short and longer term mortality was lower among people who received such care than among those who received low adherence care.
- 12 June 2024
- Published by Elsevier in Archives of Gerontology and Geriatrics
- Vol. 126, 105519
Variation in mortality following hip fracture across the Asia Pacific region: Systematic review and proportional meta-analysis
- 12 June 2024
- Published by Elsevier in Archives of Gerontology and Geriatrics
- Vol. 126, 105519
Variation in mortality following hip fracture across the Asia Pacific region: Systematic review and proportional meta-analysis
- Open Access
- 15 May 2024
- Published by Elsevier in Fire Safety Journal
- Vol. 146
Economic costs of responders for responding to residential fire incidents in new south wales, Australia
- 15 May 2024
- Published by Elsevier in Fire Safety Journal
- Vol. 146
Open AccessEconomic costs of responders for responding to residential fire incidents in new south wales, Australia
- 21 March 2024
- Published by Elsevier in Archives of Gerontology and Geriatrics
- Vol. 123, 105422
Incidence of fragility hip fracture across the Asia-pacific region: A systematic review
- 21 March 2024
- Published by Elsevier in Archives of Gerontology and Geriatrics
- Vol. 123, 105422
Incidence of fragility hip fracture across the Asia-pacific region: A systematic review
- Open Access
- 25 January 2024
- Published by Wiley in Australasian Journal on Ageing
- Vol. 43 (1) , 31-42
Improving hip fracture care: A five‐year review of the early contributors to the Australian and New Zealand Hip Fracture Registry
Objective The aim of this study was to examine temporal trends (2016-2020) in hip fracture care in Australian and New Zealand (ANZ) hospitals that started providing patient-level data to the ANZ Hip Fracture Registry (ANZHFR) on/before 1 January 2016 (early contributors). Methods Retrospective cohort study of early contributor hospitals (n = 24) to the ANZHFR. The study cohort included patients aged >= 50 years admitted with a low trauma hip fracture between 1 January 2016 and 31 December 2020 (n = 26,937). Annual performance against 11 quality indicators and 30- and 365-day mortality were examined. Results Compared to 2016/2017, year-on-year improvements were demonstrated for preoperative cognitive assessment (2020: OR 3.57, 95% confidence interval [95% CI] 3.29-3.87) and nerve block use prior to surgery (2020: OR 4.62, 95% CI 4.17-5.11). Less consistent improvements over time from 2016/2017 were demonstrated for emergency department (ED) stay of <4 h (2017; 2020), pain assessment <= 30 min of ED presentation (2020), surgery <= 48 h (2020) and bone protection medication prescribed on discharge (2017-2020; 2020 OR 2.22, 95% CI 2.03-2.42). The odds of sustaining a hospital-acquired pressure injury increased in 2019-2020 compared to 2016. The odds of receiving an orthogeriatric model of care and being offered the opportunity to mobilise on Day 1 following surgery fluctuated. There was a reduction in 365-day mortality in 2020 compared to 2016 (OR 0.86, 95% CI 0.74-0.98), whereas 30-day mortality did not change. Conclusions Several quality indicators improved over time in early contributor hospitals. Indicators that did not improve may be targets for future care improvement activities, including considering incentivised hip fracture care, which has previously been shown to improve care/outcomes. COVID-19 and reporting practices may have impacted the study findings.
- 25 January 2024
- Published by Wiley in Australasian Journal on Ageing
- Vol. 43 (1) , 31-42
Open AccessImproving hip fracture care: A five‐year review of the early contributors to the Australian and New Zealand Hip Fracture Registry
Objective The aim of this study was to examine temporal trends (2016-2020) in hip fracture care in Australian and New Zealand (ANZ) hospitals that started providing patient-level data to the ANZ Hip Fracture Registry (ANZHFR) on/before 1 January 2016 (early contributors). Methods Retrospective cohort study of early contributor hospitals (n = 24) to the ANZHFR. The study cohort included patients aged >= 50 years admitted with a low trauma hip fracture between 1 January 2016 and 31 December 2020 (n = 26,937). Annual performance against 11 quality indicators and 30- and 365-day mortality were examined. Results Compared to 2016/2017, year-on-year improvements were demonstrated for preoperative cognitive assessment (2020: OR 3.57, 95% confidence interval [95% CI] 3.29-3.87) and nerve block use prior to surgery (2020: OR 4.62, 95% CI 4.17-5.11). Less consistent improvements over time from 2016/2017 were demonstrated for emergency department (ED) stay of <4 h (2017; 2020), pain assessment <= 30 min of ED presentation (2020), surgery <= 48 h (2020) and bone protection medication prescribed on discharge (2017-2020; 2020 OR 2.22, 95% CI 2.03-2.42). The odds of sustaining a hospital-acquired pressure injury increased in 2019-2020 compared to 2016. The odds of receiving an orthogeriatric model of care and being offered the opportunity to mobilise on Day 1 following surgery fluctuated. There was a reduction in 365-day mortality in 2020 compared to 2016 (OR 0.86, 95% CI 0.74-0.98), whereas 30-day mortality did not change. Conclusions Several quality indicators improved over time in early contributor hospitals. Indicators that did not improve may be targets for future care improvement activities, including considering incentivised hip fracture care, which has previously been shown to improve care/outcomes. COVID-19 and reporting practices may have impacted the study findings.
- Open Access
Economic Costs of Residential Fires: A Systematic Review
Globally, most fire-related deaths and injuries occur in residential areas. The aim of this systematic review is to report on the economic costs of residential fires from a societal perspective. Five databases (MEDLINE, EMBASE, EconLit, CINAHL, and Scopus) and grey literature were searched to identify studies that report economic or societal costs of residential fires with data from 1978 to 2021. There were no restrictions on study design. A narrative synthesis was undertaken based on the societal and economic costs reported for each included study. Seven studies from the United States, Canada, Australia, and Kuwait reported costs of residential fires. The costs of injuries and deaths were between USD 12 million and USD 5 billion, and between USD 75 million and USD 26 billion, respectively. The costs of treatment ranged from USD 0.3 million to USD 551 million, lost productivity from USD 12 million to USD 4 billion, and property damage from USD 8 million to USD 10 billion. This systematic review provides the most comprehensive evidence to date on the economic costs of residential fires. This study would offer insights into the effects of residential fires on diverse economic agents and aid in community fire prevention messaging and incentives.
Open AccessEconomic Costs of Residential Fires: A Systematic Review
Globally, most fire-related deaths and injuries occur in residential areas. The aim of this systematic review is to report on the economic costs of residential fires from a societal perspective. Five databases (MEDLINE, EMBASE, EconLit, CINAHL, and Scopus) and grey literature were searched to identify studies that report economic or societal costs of residential fires with data from 1978 to 2021. There were no restrictions on study design. A narrative synthesis was undertaken based on the societal and economic costs reported for each included study. Seven studies from the United States, Canada, Australia, and Kuwait reported costs of residential fires. The costs of injuries and deaths were between USD 12 million and USD 5 billion, and between USD 75 million and USD 26 billion, respectively. The costs of treatment ranged from USD 0.3 million to USD 551 million, lost productivity from USD 12 million to USD 4 billion, and property damage from USD 8 million to USD 10 billion. This systematic review provides the most comprehensive evidence to date on the economic costs of residential fires. This study would offer insights into the effects of residential fires on diverse economic agents and aid in community fire prevention messaging and incentives.
- Open Access
- 14 June 2023
- Published by Wiley in Anz Journal of Surgery
- Vol. 93 (7-8) , 1917-1923
The impact of fixation type for intertrochanteric femoral fracture on patient survival
Background: Intramedullary (IM) nail fixation for intertrochanteric fractures is potentially associated with improved postoperative function but may have an increased mortality risk compared to sliding hip screw (SHS) fixation. This study investigated postoperative mortality risk between surgical fixation type for intertrochanteric fracture in patients aged 50 years and older using linked data from the Australian Hip Fracture Registry and National Death Index. Methods: Descriptive analysis and Kaplan–Meier survival curves performed unadjusted analysis of mortality and fixation type (short IM nail, long IM nail and SHS). Multilevel logistic regression (AMLR) and Cox modelling (CM) performed adjusted analysis of fixation type and mortality following surgery. Instrumental variable analysis (IVA) was conducted to minimize the effect of unknown confounders. Results: The 30‐day mortality was 7.1% for short IM, 7.8% for long IM and 7.8% for SHS fixation ( P = 0.2). The AMLR demonstrated significant increase in 30‐day mortality risk for long IM nail compared to short IM nail (OR = 1.2, 95% CI = 1.0–1.4, P < 0.05) but no significant difference for SHS fixation (OR = 1.1, 95% CI = 0.9–1.3, P = 0.5). No significant difference between groups and postoperative mortality was demonstrated by the CM at 30‐days nor 1‐year nor by the IVA at 30‐days. Conclusion: Despite a significant increase in 30‐day mortality risk for long IM nail compared to short IM nail fixation in the adjusted analysis, this was not demonstrated in the CM nor IVA indicating the role of confounders influencing the regression findings. There was no significant association in 1‐year mortality between long IM nail and SHS compared to short IM nail fixation.
- 14 June 2023
- Published by Wiley in Anz Journal of Surgery
- Vol. 93 (7-8) , 1917-1923
Open AccessThe impact of fixation type for intertrochanteric femoral fracture on patient survival
Background: Intramedullary (IM) nail fixation for intertrochanteric fractures is potentially associated with improved postoperative function but may have an increased mortality risk compared to sliding hip screw (SHS) fixation. This study investigated postoperative mortality risk between surgical fixation type for intertrochanteric fracture in patients aged 50 years and older using linked data from the Australian Hip Fracture Registry and National Death Index. Methods: Descriptive analysis and Kaplan–Meier survival curves performed unadjusted analysis of mortality and fixation type (short IM nail, long IM nail and SHS). Multilevel logistic regression (AMLR) and Cox modelling (CM) performed adjusted analysis of fixation type and mortality following surgery. Instrumental variable analysis (IVA) was conducted to minimize the effect of unknown confounders. Results: The 30‐day mortality was 7.1% for short IM, 7.8% for long IM and 7.8% for SHS fixation ( P = 0.2). The AMLR demonstrated significant increase in 30‐day mortality risk for long IM nail compared to short IM nail (OR = 1.2, 95% CI = 1.0–1.4, P < 0.05) but no significant difference for SHS fixation (OR = 1.1, 95% CI = 0.9–1.3, P = 0.5). No significant difference between groups and postoperative mortality was demonstrated by the CM at 30‐days nor 1‐year nor by the IVA at 30‐days. Conclusion: Despite a significant increase in 30‐day mortality risk for long IM nail compared to short IM nail fixation in the adjusted analysis, this was not demonstrated in the CM nor IVA indicating the role of confounders influencing the regression findings. There was no significant association in 1‐year mortality between long IM nail and SHS compared to short IM nail fixation.